Samrat Pharmachem informs about approval of un-audited financial results

10 Feb 2022 Evaluate

Samrat Pharmachem has informed that the Board of Directors of the Company at its meeting held today i.e., Thursday, February 10, 2022, has considered and took on record the attached Un-Audited Standalone Financial Results of the Company for the quarter ended December 31, 2021, which is enclosed along with the Limited Review Report of the Statutory Auditor of the Company. The meeting of the Board of Directors of the Company commenced at 14:30 hrs and concluded at 15:30 hrs.

The above information is a part of company’s filings submitted to BSE.

Samrat Pharmachem Share Price

479.90 3.50 (0.73%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.